Recent Discoveries & Advances

Recent Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our blog, On Cancer.

Search by keywords:

139 News Items found

In the Clinic

Combination Immunotherapy Produces Striking Results against Melanoma

Giving two immunotherapy drugs together produced dramatic results in patients with advanced melanoma.

A smiling physician in white coat talking to patient whose back is to the camera.

In the Lab

Why a New Immunotherapy for Lung Cancer Works for Only Some People

According to an MSK study, a powerful immunotherapy drug for lung cancer works better in people whose tumors carry a lot of mutations caused by tobacco smoke.

Cancer genomics researcher Timothy Chan

In the Lab

Outsmarting Cancer’s Survival Skills

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.

MSK investigators Joan Massagué and Anna Obenauf

Feature

The Future of Cancer: Five Reasons for Optimism

Learn about five hot science areas that are changing the way we understand and treat cancer.

In the Clinic

“Living Therapies” Developed at MSK Provide New Approach for Cancer Treatment

Cell therapies that use patients’ own immune cells to attack cancer are a promising and rapidly growing area of research.

CAR T cell immunotherapy

Decoder

What Are Exceptional Responders?

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Exceptional responders of new drugs in clinical trials.

Announcement

Expanding the Impact of Precision Medicine to Fuel Discoveries

MSK’s Functional Genomics Initiative will enable basic scientists to take full advantage of the massive amount of data produced by tumor sequencing.

Christina Leslie and John Petrini

In the Lab

Can Stem Cells Be Taught to Repair a Radiation-Damaged Brain?

In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.

Fibrous extensions of a nerve cell (red) and an oligodendrocyte (green) growing on top of the nerve cell

In the Clinic

Smoking May Interfere with Radiation Treatment for Prostate Cancer

Researchers call for intensified efforts to help men with prostate cancer quit smoking after a recent MSK study revealed that patients who smoke during radiation therapy face a higher risk of both having the disease return and dying from it.

Pictured: Michael Zelefsky

Q&A

Setting Cancer Cells on the Right Path: A New Leukemia Drug Shows Growing Promise

An experimental drug for acute myelogenous leukemia might potentially help many more patients than previously thought by controlling epigenetic processes, according to a recent MSK study.

Epigenetics